A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis

por Evertsson, Björn, Hoyt, Tammy, Christensen, Angel, Nimer, Faiez AL, Foley, John, Piehl, Fredrik
Publicado 2020